Related references
Note: Only part of the references are listed.Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tamara Pringsheim et al.
DRUG SAFETY (2011)
Management of Schizophrenia in Children and Adolescents Focus on Pharmacotherapy
Gabriele Masi et al.
DRUGS (2011)
Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross-sectional study
Jackie Curtis et al.
EARLY INTERVENTION IN PSYCHIATRY (2011)
Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons
David Fraguas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Haematological toxicity of clozapine and some other drugs used in psychiatry
Patty M. M. Nooijen et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)
Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
Lawrence Maayan et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2011)
Dried blood spots, pharmacokinetic studies and better medicines for children
Hitesh C. Pandya et al.
BIOANALYSIS (2011)
Treatment of early-onset schizophrenia
Anand K. Mattai et al.
CURRENT OPINION IN PSYCHIATRY (2010)
Plasma Clozapine and Norclozapine in Patients Prescribed Different Brands of Clozapine (Clozaril, Denzapine, and Zaponex)
Lewis Couchman et al.
THERAPEUTIC DRUG MONITORING (2010)
Plasma Clozapine, Norclozapine, and the Clozapine: Norclozapine Ratio in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 1993-2007
Lewis Couchman et al.
THERAPEUTIC DRUG MONITORING (2010)
New advances in pharmacotherapy for early psychosis
Robin Emsley
EARLY INTERVENTION IN PSYCHIATRY (2009)
Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns
Benedetto Vitiello et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizoaffective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
Linmarie Sikich et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Clozapine and high-dose olanzapine in refractory early-onset schizophrenia: A 12-week randomized and double-blind comparison
Sanjiv Kumra et al.
BIOLOGICAL PSYCHIATRY (2008)
Clozapine use in children and adolescents
Nitin Gogtay et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: A retrospective study in Korean children and adolescents
Yeni Kim et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Clozapine versus High-Dose olanzapine in refractory early-onset schizophrenia: An open-label extension study
Sanjiv Kumra et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2008)
Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone
Christian Fleischhaker et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables
F. J. Diaz et al.
PHARMACOPSYCHIATRY (2008)
Who are the new users of antipsychotic medications?
Marisa Elena Domino et al.
PSYCHIATRIC SERVICES (2008)
Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients
Christoph U. Correll
INTERNATIONAL REVIEW OF PSYCHIATRY (2008)
The Maudsley early onset schizophrenia study - Predictors of psychosocial outcome at 4-year follow-up
Nora S. Vyas et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2007)
Clozapine treatment of childhood-onset schizophrenia: Evaluation of effectiveness, adverse effects, and long-term outcome
Alexandra L. Sporn et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)
Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration
Babur Yusufi et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Clozapine-induced seizures: Recognition and treatment
Jason Wong et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2007)
Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways
Lukas Cerveny et al.
DRUG METABOLISM AND DISPOSITION (2007)
Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents
C. Fleischhaker et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Decision making about children with psychotic symptoms: Using the best evidence in choosing a treatment
Philip Shaw et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2006)
Childhood-onset schizophrenia - A double-blind, randomized clozapine-olanzapine comparison
Philip Shaw et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Clinical drug monitoring in child and adolescent psychiatry: Side effects of atypical neuroleptics
Christian Fleischhaker et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)
Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients
JOY Wong et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Clozapine prescribing in adolescent psychiatry: survey of prescribing practice in in-patient units
Giovanni Cirulli
PSYCHIATRIC BULLETIN (2005)
Therapeutic monitoring of new antipsychotic drugs
C Hiemke et al.
THERAPEUTIC DRUG MONITORING (2004)
Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: A predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients
A Rostami-Hodjegan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Increased developmental deviance and premorbid dysfunction in early onset schizophrenia
A Vourdas et al.
SCHIZOPHRENIA RESEARCH (2003)
Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine
CL Alfaro et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2002)
Share Paper
